Skip to content

Clinical trials

Terminated Mucopolysaccharidosis II trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis II Status: Terminated Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20112
20141
20171
20181
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sangamo Therapeutics2
Aldagen1
CENTOGENE GmbH Rostock1
Duke University1
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center1
National MPS Society1
Shire1
Talaris Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis II9
Sudden Infant Death7
Mucopolysaccharidosis I6
Mucopolysaccharidosis VI4
Mucopolysaccharidoses3
Adrenoleukodystrophy2
Leukodystrophy, Globoid Cell2
Leukodystrophy, Metachromatic2
Mucopolysaccharidosis III2
Sandhoff Disease2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.